NO20012555D0 - Fremgangsmåte for å fremme cervikale og vaginale sekresjoner - Google Patents

Fremgangsmåte for å fremme cervikale og vaginale sekresjoner

Info

Publication number
NO20012555D0
NO20012555D0 NO20012555A NO20012555A NO20012555D0 NO 20012555 D0 NO20012555 D0 NO 20012555D0 NO 20012555 A NO20012555 A NO 20012555A NO 20012555 A NO20012555 A NO 20012555A NO 20012555 D0 NO20012555 D0 NO 20012555D0
Authority
NO
Norway
Prior art keywords
procedure
vaginal secretions
promoting cervical
cervical
promoting
Prior art date
Application number
NO20012555A
Other languages
English (en)
Other versions
NO20012555L (no
Inventor
William Pendergast
Sammy R Shaver
David J Drutz
Janet L Rideout
Original Assignee
Inspire Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inspire Pharmaceuticals Inc filed Critical Inspire Pharmaceuticals Inc
Publication of NO20012555D0 publication Critical patent/NO20012555D0/no
Publication of NO20012555L publication Critical patent/NO20012555L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20012555A 1998-11-25 2001-05-23 Fremgangsmåte for å fremme cervikale og vaginale sekresjoner NO20012555L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/199,912 US6462028B2 (en) 1997-07-25 1998-11-25 Method of promoting cervical and vaginal secretions
PCT/US1999/027634 WO2000030629A2 (en) 1998-11-25 1999-11-19 Method of promoting cervical and vaginal secretions

Publications (2)

Publication Number Publication Date
NO20012555D0 true NO20012555D0 (no) 2001-05-23
NO20012555L NO20012555L (no) 2001-07-24

Family

ID=22739534

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012555A NO20012555L (no) 1998-11-25 2001-05-23 Fremgangsmåte for å fremme cervikale og vaginale sekresjoner

Country Status (12)

Country Link
US (2) US6462028B2 (no)
EP (1) EP1133304A2 (no)
JP (1) JP2003524609A (no)
KR (1) KR20010101066A (no)
CN (1) CN1348378A (no)
AU (1) AU764452B2 (no)
BR (1) BR9915636A (no)
CA (1) CA2352262A1 (no)
ID (1) ID29801A (no)
NO (1) NO20012555L (no)
WO (1) WO2000030629A2 (no)
ZA (1) ZA200104310B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319908B1 (en) 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US7223744B2 (en) 1997-02-10 2007-05-29 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising dinucleoside polyphosphates and salts thereof
US7078391B2 (en) 1997-02-10 2006-07-18 Inspire Pharmaceuticals, Inc. Method of treating edematous retinal disorders
US6818629B2 (en) 1997-02-10 2004-11-16 Inspire Pharmaceuticals, Inc. Pharmaceutical formulation comprising P1-(2'-deoxycytidine 5'-)P4-(uridine 5'-) tetraphosphate
US6596725B2 (en) 1997-02-10 2003-07-22 Inspire Pharmaceuticals, Inc. Use of certain dinucleotides to stimulate removal of fluid in retinal detachment and retinal edema
TW593331B (en) 1997-07-25 2004-06-21 Inspire Pharmaceuticals Inc Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof
BRPI9810436B1 (pt) 1997-07-25 2015-12-29 Inspire Pharmaceuticals Inc processo para a produção em larga escala de di (5'-tetrafosfato de uridina) e sais do mesmo
US6462028B2 (en) 1997-07-25 2002-10-08 Inspire Pharmaceuticals, Inc. Method of promoting cervical and vaginal secretions
US6872710B2 (en) 1997-07-25 2005-03-29 Inspire Pharmaceuticals, Inc. Di(uridine 5′)-tetraphosphate and salts thereof
US6555675B2 (en) * 2000-08-21 2003-04-29 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapuetic use as purinergic receptor agonists
US7452870B2 (en) 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US6867199B2 (en) 2000-08-21 2005-03-15 Inspire Pharmaceuticals, Inc. Dinucleoside polyphosphate compositions and their therapeutic use
JP2005508297A (ja) 2001-06-25 2005-03-31 インスパイアー ファーマシューティカルズ，インコーポレイティド Ｐ２ｙプリン受容体作用物質による関節潤滑
KR20050043761A (ko) 2001-11-06 2005-05-11 인스파이어 파마슈티컬스 인코퍼레이티드 염증성 질환의 치료 또는 예방 방법
EP1348466A3 (en) * 2002-02-01 2003-10-29 Inspire Pharmaceuticals, Inc. Method for treating pain with adenosine-tetraphosphates
US20050176782A1 (en) * 2002-02-26 2005-08-11 Easterling W. J. Medicament and method for treating vulodynia
US20030162769A1 (en) * 2002-02-26 2003-08-28 Easterling W. Jerry Composition and method for treating vulvodynia
US7179481B2 (en) * 2002-09-19 2007-02-20 Kimberly-Clark Worldwide, Inc. Vaginal health products
CN1700894A (zh) * 2002-10-18 2005-11-23 莫利化学医药公司 使用羊毛硫抗生素治疗干眼病的方法
US7056889B2 (en) * 2002-12-16 2006-06-06 Kimberly-Clark, Worldwide, Inc. Compounds that bind P2Y2 or P2Y1 receptors
GB0312845D0 (en) * 2003-06-04 2003-07-09 Paradigm Therapeutics Ltd Use of componds in medicine
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
EP1750740A4 (en) * 2004-05-06 2009-06-10 Molichem Medicines Inc TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING COMPOSITIONS CONTAINING LANTIBIOTICS
US8147399B2 (en) 2004-05-11 2012-04-03 Gloth David A Device and method for applying a biocompatible substance to a female stimulation device
US6949067B1 (en) * 2004-05-11 2005-09-27 Dann Jeffrey A Device and method for enhancing female sexual stimulation
GB0417886D0 (en) * 2004-08-11 2004-09-15 Univ Cardiff Method and means for enhanced pulmonary delivery
DE102004054552A1 (de) 2004-11-11 2006-05-18 Hcb Happy Child Birth Holding Ag Neue Zusammensetzung zur Erleichterung der Humangeburt
US7368439B2 (en) 2005-06-15 2008-05-06 Bar - Ilan University Dinucleoside poly(borano)phosphate derivatives and uses thereof
GB201209244D0 (en) * 2012-05-25 2012-07-04 Globalacorn Ltd Compositions
EP2906302A1 (en) * 2012-10-12 2015-08-19 Inoflex AB Composition for alleviating conditions associated with vaginal dryness
GB201320962D0 (en) * 2013-11-27 2014-01-08 Globalacorn Ltd Compositions
GB201320959D0 (en) * 2013-11-27 2014-01-08 Globalacorn Ltd Compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639561A (en) 1970-04-29 1972-02-01 Smith Kline French Lab Vaginal suppositories and impregnated tampons
US3639562A (en) 1970-04-29 1972-02-01 Smith Kline French Lab Vaginal suppositories and impregnated tampons
EP0566135A1 (en) * 1992-04-17 1993-10-20 Takeda Chemical Industries, Ltd. Transmucosal composition comprising a peptide and a cytidine derivative
JPH05346549A (ja) 1992-04-17 1993-12-27 Canon Inc 走査光学装置
US5635160A (en) 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
IT1277373B1 (it) * 1995-07-28 1997-11-10 Consiglio Nazionale Ricerche Impiego di composti agonisti o antagonisti dei recettori purinici p2 per la prevenzione della citotossicita' da glutammato
US6423694B1 (en) 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
US5900407A (en) 1997-02-06 1999-05-04 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with uridine triphosphates and related compounds
US5837861A (en) * 1997-02-10 1998-11-17 Inspire Pharmaceuticals, Inc. Dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency
CN1229114C (zh) 1996-03-27 2005-11-30 印斯拜尔药品股份有限公司 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法
US5789391A (en) 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US6319908B1 (en) * 1996-07-03 2001-11-20 Inspire Pharmaceuticals, Inc. Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
NZ337225A (en) 1997-02-06 2002-03-28 Inspire Pharmaceuticals Inc Dinucleotides useful for treating chronic pulmonary obstructive disorder
US6462028B2 (en) 1997-07-25 2002-10-08 Inspire Pharmaceuticals, Inc. Method of promoting cervical and vaginal secretions
BRPI9810436B1 (pt) 1997-07-25 2015-12-29 Inspire Pharmaceuticals Inc processo para a produção em larga escala de di (5'-tetrafosfato de uridina) e sais do mesmo
US6294188B1 (en) 1998-07-09 2001-09-25 Aviana Biopharm Inc. Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women

Also Published As

Publication number Publication date
US20020013289A1 (en) 2002-01-31
CN1348378A (zh) 2002-05-08
ZA200104310B (en) 2002-10-24
KR20010101066A (ko) 2001-11-14
WO2000030629A3 (en) 2001-06-07
BR9915636A (pt) 2002-12-24
EP1133304A2 (en) 2001-09-19
WO2000030629A2 (en) 2000-06-02
NO20012555L (no) 2001-07-24
ID29801A (id) 2001-10-11
AU1741200A (en) 2000-06-13
AU764452B2 (en) 2003-08-21
JP2003524609A (ja) 2003-08-19
CA2352262A1 (en) 2000-06-02
US20080214490A1 (en) 2008-09-04
US6462028B2 (en) 2002-10-08

Similar Documents

Publication Publication Date Title
NO20012555D0 (no) Fremgangsmåte for å fremme cervikale og vaginale sekresjoner
GB9929826D0 (en) Vaginal and cervical lacerations aid
NO990945D0 (no) Vanndispergerbar og nedspylbar, interlabial absorberende struktur
NO20004947L (no) Presipitert kalsiumkarbonat og fremstilling og anvendelse derav
GB2356147B (en) Bone alignment and fixation device
DE29509191U1 (de) Orthopädische Operationsvorrichtung
AU3885600A (en) Splint bandage and method
AU2224699A (en) Soft tissue fixation devices
DE59701304D1 (de) Wirbelsäulenorthese
DE69910462D1 (de) Cervicalorthese
FR2775181B1 (fr) Speculum vaginal
NO990914D0 (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
NO20013085D0 (no) Fosfororganiske forbindelser og deres anvendelse
DK1178981T3 (da) Substituerede 3-pyridyl-4-arylpyrroler og deres terapeutiske og profylaktiske anvendelser
GB2338701B (en) Patient transfer aid
GB2335602B (en) Surgical speculum
DE29609276U1 (de) Chirurgisches Biegegerät
GB2341320B (en) Vaginal speculum
DE29812144U1 (de) Wärmende Bandage
NO20014827L (no) Fremgangsmåter for å modulere human seksualrespons
IT1304818B1 (it) Strumento chirurgico ad impiego universale, ed in particolareortopedico.
DE29809038U1 (de) Chirurgisches Gerät
DE69425878D1 (de) Cervicalorthese
DE29902567U1 (de) Dynamisierte Reklinationsorthese mit Sternalpelotte
DE29905488U1 (de) Fixier-Verband

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application